GlassScriptPhysician profile
Yung S Chen
NPI 1366411845
$823.94
in general payments reported to CMS, 2019-2025
13 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $126 · 2021: $48.76 · 2022: $97.49 · 2023: $95.77 · 2024: $82.55 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.02 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $383.63 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $104.61 | 2021-2025 | Vraylar |
| Supernus Pharmaceuticals, INC. | $69.82 | 2022 | |
| Novo Nordisk INC | $51.96 | 2019 | |
| Hologic Sales and Service, LLC | $41.95 | 2025 | Aptima |
| Merck Sharp & Dohme LLC | $37.32 | 2019 | |
| Glaxosmithkline, LLC. | $30.46 | 2021 | |
| Corium, LLC | $20.98 | 2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2024 | |
| Cipher Pharmaceuticals US LLC | $17.82 | 2025 | Spinosad, Natroba |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.96 | 2019 | |
| Ethicon US, LLC | $15.77 | 2019 | |
| Pfizer INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yung Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.